Xospata (gilteritinib)

pCPA File Number: 21257

Negotiation Status:

Concluded with an LOI

Indication(s):

Acute Myeloid Leukemia

Sponsor/Manufacturer:

Astellas Pharma Inc.

CADTH Project Number:

pCODR 10202

pCPA Engagement Letter Issued:

2020-08-17

Negotiation Process Concluded:

2021-03-15